Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects
Clinical trial NCT04514796 · COMPLETED
Trial details
- NCT number
- NCT04514796
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2021-05-15
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.